Nadim Ahmed
EVP and President, Hematology, Bristol-Myers Squibb.
Companies
- Disc Medicine, Inc.Board member Jul 16, 2025 to now1
- Cullinan OncologyBoard member Oct 20, 2021 to now2
- Cullinan OncologyChief executive officer Oct 20, 2021 to now2
- Cullinan OncologyPresident Oct 20, 2021 to now2
- Bristol-Myers SquibbEVP and President, Hematology Mar 12, 2020 to Jan 5, 20213
- Bristol-Myers SquibbPresident Nov 27, 2019 to Mar 3, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cullinan Oncology CGEM390,803 shares5$5.3M at $13.68Feb 24, 2026
Bristol-Myers Squibb BMY40,855 shares6$2.4M at $59.67Jan 5, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 24, 2026Sold 13,515 shares at $14.47 of Cullinan Oncology5
- Feb 20, 2026Sold 16,381 shares at $13.62 of Cullinan Oncology7
- Dec 23, 2025Sold 9,922 shares at $10.01 of Cullinan Oncology8
- Feb 25, 2025Sold 12,529 shares at $8.53 of Cullinan Oncology9
- Feb 19, 2025Granted 180,000 shares of Cullinan Oncology10
- Dec 24, 2024Sold 8,400 shares at $11.87 of Cullinan Oncology11
- Feb 22, 2024Granted 160,000 shares of Cullinan Oncology12
- Dec 26, 2023Sold 4,272 shares at $9.24 of Cullinan Oncology13
- Jun 28, 2023Sold 759 shares at $11.40 of Cullinan Oncology14
- May 23, 2023Sold 707 shares at $9.15 of Cullinan Oncology15
- Apr 25, 2023Sold 716 shares at $10.59 of Cullinan Oncology16
- Mar 23, 2023Sold 706 shares at $10.51 of Cullinan Oncology17
- Feb 22, 2023Granted 109,000 shares of Cullinan Oncology18
- Jun 30, 2022Granted 1,620 shares at $10.90 of Cullinan Oncology19
- Jun 6, 2022Bought 8,090 shares at $12.40 of Cullinan Oncology20
- Dec 31, 2020Shares withheld for tax 7,660 shares at $62.03 of Bristol-Myers Squibb6
- Dec 31, 2020Exercised options 14,946 shares of Bristol-Myers Squibb6
- Dec 2, 2020Shares withheld for tax 3,380 shares at $62.18 of Bristol-Myers Squibb21
- Dec 2, 2020Exercised options 6,594 shares of Bristol-Myers Squibb21
- Oct 30, 2020Shares withheld for tax 2,291 shares at $58.45 of Bristol-Myers Squibb22
- Oct 30, 2020Exercised options 4,650 shares of Bristol-Myers Squibb22
- May 1, 2020Shares withheld for tax 1,433 shares at $60.26 of Bristol-Myers Squibb23
- May 1, 2020Exercised options 2,908 shares of Bristol-Myers Squibb23
- Mar 1, 2020Shares withheld for tax 8,473 shares at $59.06 of Bristol-Myers Squibb24
- Mar 1, 2020Exercised options 17,204 shares of Bristol-Myers Squibb24
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARDisc Medicine, Inc., Board member
- 2SEC EDGARCullinan Oncology, Board member
- 3
- 4SEC EDGARBristol-Myers Squibb, President
- 5
- 6
- 7SEC EDGARForm 4 filed Feb 23, 2026
- 8SEC EDGARForm 4 filed Dec 29, 2025
- 9SEC EDGARForm 4 filed Feb 27, 2025
- 10SEC EDGARForm 4 filed Feb 21, 2025
- 11SEC EDGARForm 4 filed Dec 27, 2024
- 12SEC EDGARForm 4 filed Feb 23, 2024
- 13SEC EDGARForm 4 filed Dec 27, 2023
- 14SEC EDGARForm 4 filed Jun 29, 2023
- 15SEC EDGARForm 4 filed May 24, 2023
- 16SEC EDGARForm 4 filed Apr 26, 2023
- 17SEC EDGARForm 4 filed Mar 27, 2023
- 18SEC EDGARForm 4 filed Feb 23, 2023
- 19SEC EDGARForm 4 filed Jul 5, 2022
- 20SEC EDGARForm 4 filed Jun 7, 2022
- 21SEC EDGARForm 4 filed Dec 3, 2020
- 22SEC EDGARForm 4 filed Nov 3, 2020
- 23SEC EDGARForm 4 filed May 5, 2020
- 24SEC EDGARForm 4 filed Mar 3, 2020